Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Dec 19, 2023

BUY
$3.17 - $5.82 $493,565 - $906,168
155,699 Added 329.22%
202,992 $690,000
Q2 2023

Aug 15, 2023

BUY
$3.17 - $5.82 $493,565 - $906,168
155,699 Added 329.22%
202,992 $690,000
Q1 2023

Dec 19, 2023

BUY
$3.94 - $7.05 $186,334 - $333,415
47,293 New
47,293 $186,000
Q1 2023

May 15, 2023

BUY
$3.94 - $7.05 $186,334 - $333,415
47,293 New
47,293 $186,000

Others Institutions Holding ALVR

About Allovir, Inc.


  • Ticker ALVR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,063,400
  • Market Cap $51.2M
  • Description
  • Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...
More about ALVR
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.